DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Acamprosate
Acamprosate
Appendix a Common Abbreviations Used in Medication
Medication Assisted Treatment MAT
Evidence-Based Guidelines for the Pharmacological Management of Substance Abuse, Harmful Use, Addictio
Michael F. Weaver, MD, DFASAM PRESENT TITLE
Treatment of Patients with Substance Use Disorders Second Edition
Acamprosate in the Treatment of Binge Eating Disorder: a Placebo-Controlled Trial
The Use of Central Nervous System Active Drugs During Pregnancy
Treating Substance Abuse •
W08. Update in Addiction Medicine
View the Scientific Program Abstracts of the ACAAM 2020 Annual Meeting
CAMPRAL (Acamprosate Calcium)
Currently Prescribed Psychotropic Medications
Pharmacological Management of Alcohol Use Disorders
Office Based Management of Alcohol Withdrawal and Prescribing
Substance Abuse and Treatment
Review of Existing Classification Efforts
Assessment and Treatment of Alcohol Dependence Suggested Citation: Quigley, A., Connolly, C., Palmer, B., & Helfgott, S
Is It Time for Baclofen to Be Included in the Official Recommendations Concerning the Treatment of Alcoholism?
Top View
Correlates of Baclofen Effectiveness in Alcohol Dependence
Campral (Acamprosate Calcium) - Draft-Labeling-Text-Tracked Page 1 of 10
Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
Substance Use Disorders and Risk for Treatment Resistant Depression: a Population-Based, Nested Case-Control Study
Acamprosate Axis 1 Class Glutamate
Opioid Detoxification
Acamprosate Calcium Campral® – Prempharm Inc
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Effectiveness of Acamprosate in the Treatment of Alcohol Dependence WILLIAM E
Practice Guideline for the Treatment of Patients with Substance Use Disorders, 2Nd Edition
A Clinician's Guide Prescribing Medications for Alcohol Dependence
Treatment‐Resistant Depression As Risk Factor for Substance Use Disorders
TIP 49 Incorporating Alcohol Pharmacotherapies Into Medical
Management of Alcohol, Opioid And
Pharmacotherapy for Alcohol Use Disorder in Patients with Hepatic Impairment
Alcohol Dependence and Harmful Alcohol
Interpretation of Drug Testing Results in Medication Assisted Treatment
Integrating Addiction Medicine Into Addiction Treatment
Medications for Substance Use Disorders
Precision Medicine in Alcohol Dependence: a Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes
Long-Term Drug Treatment of Patients with Alcohol Dependence
Acamprosate: an Alcoholism Treatment That May Not Be What We Thought
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone Barbara J
MAT for Alcohol Use Disorder
Medicaid Coverage of Medication-Assisted Treatment For
Acamprosate: a New Medication for Alcohol Use Disorders
List of Selected Drugs
Prinicples of Drug Addiction Treatment
Medication for the Treatment of Alcohol Use Disorder: a Brief Guide
Interactions Between Opioids and Alcohol Dr
Study Characteristics for Acamprosate + Naltrexone
Treatment Interventions to Maintain Abstinence from Alcohol in Primary
Addiction Meds – Understanding Medication-Assisted Treatment For
Alcohol Use Treatment Rev. 1/2019
WO 2016/179252 Al 10 November 2016 (10.11.2016) P O P C T
Acamprosate (Campral )
Underutilization of Pharmacotherapy for Treatment of Alcohol Use
Pharmacotherapy Options for Alcohol Use Disorder
Phase 1B Pharmaco-MRS Pilot Study of Clavulanic Acid After Repeated Administration
Medication-Assisted Treatment, Addictions and Clinical Education
Naltrexone in Combination with Acamprosate for the Treatment of Alcohol Dependence: a Review of the Clinical and Cost-Effectiveness
Acamprosate for Maintaining Abstinence in Alcohol Dependent Adults Information for Primary Care
Guidance for the Use and Reduction of Misuse of Benzodiazepines and Other Hypnotics and Anxiolytics in General Practice